RETNLB Polyclonal Antibody

Rs. 16,500.00
SKU E-AB-14332


Synonyms C/EBP epsilon regulated myeloid specific secreted cysteine rich protein precursor 2,CCGR,Colon and small intestine specific cysteine rich protein,Colon and small intestine-specific cysteine-rich protein,Colon carcinoma related gene protein,Colon carcinoma-related gene protein,Cysteine rich secreted A12 alpha like protein 1,Cysteine rich secreted protein A12 alpha like 1,Cysteine rich secreted protein FIZZ2,Cysteine-rich secreted protein A12-alpha-like 1,Cysteine-rich secreted protein FIZZ2,FIZZ1,FIZZ2,Found in inflammatory zone 1,HXCP2,RELM beta,RELMb,RELMbeta,Resistin like beta,Resistin like protein beta,Resistin-like beta,RETNB,RETNL2,Retnlb,XCP2
Swissprot Q9BQ08
Source Rabbit
Reactivity Human
Immunogen Recombinant protein of human RETNLB
Application IHC,ELISA
Recommended dilution IHC 1:25-1:100
Concentration 0.1mg/mL
Clonality Polyclonal


Cellular localization  
Tissue specificity  
Isotype IgG
Purification Affinity purification
Conjugation Unconjugated
Storage instructions Store at -20℃. Avoid freeze / thaw cycles.
Storage buffer PBS with 0.05% sodium azide, 50% glycerol, PH7.3
Background Resistin-like beta is a protein that in humans is encoded by the RETNLB gene. An infusion of either resistin or RELMB in rats rapidly induced severe hepatic but not peripheral insulin resistance. Increases in circulating resistin or RELMB levels markedly stimulated hepatic glucose production despite the presence of fixed physiologic insulin levels. This enhanced rate of glucose output was due to increased flux through glucose-6-phosphatase. The results supported the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.


You recently viewed

Clear recently viewed
Print Friendly and PDF